8th Annual Psychopharmacology Update 2022

This comprehensive program will cover psychopharmacology pearls and updates across a variety of disease states including tardive dyskinesia bipolar disorder major depression opioid use disorder schizophrenia and ADHD. Materials will be available in the forms of webinar slides on-demand webcasts ClinicalThoughts and podcasts.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

Supported by educational grants from

AbbVie Inc.

Independent Educational Activity

Intra Cellular Therapies

Neurocrine Biosciences

Otsuka America Pharmaceutical, Inc. and Lundbeck

Sunovion and Otsuka America Pharmaceutical Inc